Patients with ophiasis may be categorized into 3 distinct subtypes that can guide early intervention and stratify treatment.

Promising early results regarding the use of litifilimab in patients with CLE were presented as part of a late-breaking session at the 2026 AAD Annual Meeting.

Real-world data on spesolimab have shown rapid improvement in acute flares of GPP, along with a favorable safety profile, according to a systemic review.

Blaine Labs recalls Revitaderm and Tridergel wound care gels due to microbial contamination with Lysinibacillus fusiformis.

After months of leadership changes, President Donald Trump has chosen a new candidate to lead the U.S. Centers for Disease Control and Prevention (CDC). The White House announced Thursday that Dr.

Superior efficacy and comparable safety was seen with DFD-29 in patients with rosacea when compared with the current first-line systemic.

Close to 90% of adults in the United States reported having a source of usual health care in 2024, with differences seen by age and sex.

Chatbots or other AI tools were used by around 1 in 4 American adults seeking physical or mental health information.

A new AARP report found 59 million Americans served as unpaid caregivers, working nearly 50 billion hours, valued at $1 trillion, per year.

Despite the initiation of a phase 3 confirmatory trial, the FDA remains unsatisfied with the interpretability of phase 2 data for Replimune’s oncolytic immunotherapy.

Immunocompetent adults younger than 50 years of age experience a substantial HZ burden, with incidence rates comparable to older age groups.

The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.